Prawo i regulacje · 10/12/2020

DEA Proposes to Remove Samidorphan From Controlled Substances Act Schedules

The Drug Enforcement Administration (DEA) is proposing to remove samidorphan, a schedule II controlled substance derived from opium alkaloids, from the schedules of the Controlled Substances Act (CSA) after a formal rulemaking process.